Navigation Links
Cadence Pharmaceuticals Reports First Quarter 2009 Financial Results
Date:5/7/2009

SAN DIEGO, May 7 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, today reported financial results for the first quarter ended March 31, 2009.

"We have now completed the clinical development program for Acetavance(TM), our proprietary formulation of intravenous acetaminophen for the treatment of acute pain and fever in adults and children, and plan to submit a New Drug Application for Acetavance in the second quarter of 2009," stated Ted Schroeder, President and CEO of Cadence Pharmaceuticals. "We also achieved another important corporate objective earlier this year by raising gross proceeds of $86.6 million through a private placement of common stock and warrants. We believe this additional capital strengthens our balance sheet and will enable us to prepare for the launch of Acetavance, if approved by the FDA."

In March 2009, Cadence announced that its Phase III clinical trial of Omigard(TM) (omiganan pentahydrochloride 1% topical gel) for the prevention of catheter-related infections did not meet its primary endpoint and that, as a result, the company made the strategic decision to discontinue further development of this product candidate. In order to reduce operating costs following this decision, Cadence implemented a restructuring plan, including a workforce reduction.

First Quarter 2009 Financial Results

For the first quarter ended March 31, 2009, Cadence reported a net loss of $10.4 million, or $0.24 per share, compared to a net loss of $13.7 million, or $0.42 per share, for the same period in 2008. The per share amount for the first quarter of 2009 includes the effect of the issuance of 12,039,794 shares
'/>"/>

SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Cadence Pharmaceuticals CEO Ted Schroeder to Present at Two Investment Conferences During the Month of May 2009
2. Cadence Pharmaceuticals Announces Presentations at Upcoming Scientific Conferences
3. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at BioCentury Publications Inc. Future Leaders in the Biotech Industry Conference in New York on April 2, 2009
4. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2008 Financial Results and Corporate Update on March 12, 2009
5. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the Roth Capital Partners 21st Annual OC Growth Stock Conference
6. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2008 Financial Results and Provide a Clinical Program Update on November 6, 2008
7. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the BIOCOM Investor Conference
8. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the JMP Securities Third Annual Healthcare Focus Conference
9. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the 2008 NewsMakers In the Biotech Industry Conference
10. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at Two Investment Conferences During the Month of August 2008
11. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the Leerink Swann Pain Roundtable Conference on June 23, 2008 in New York
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/6/2010)... University Belfast are developing new sensors to detect chemical ... fight against the threat of terrorist attacks. , The ... individual or crime scene to gather a sample which ... detect the presence of chemicals within seconds. This will ... to terrorist threats. , The scanning instrument will ...
(Date:2/5/2010)... . , Scientists at the University ... first time different antioxidant compounds from foods such as ... Teucrium polium. They have used two new techniques, capillary ... them to identify and quantify a great part of ... foods such as olive oil, honey, walnuts and a ...
(Date:2/5/2010)... Disease ,, COLLEGE PARK, Md. , ... Inc. ( www.renovalife.com ), a company developing research ... joined the Maryland Technology Enterprise Institute (Mtech) Technology ... ,, The privately funded company, founded in ... ,, "The most important factors [for joining TAP] ...
(Date:2/5/2010)... 5 Novavax, Inc. (Nasdaq: NVAX ... Rahul Singhvi , President and Chief Executive Officer ... BIO CEO & Investor Conference on February 8th, ... Hosted by the Biotechnology Industry Organization (BIO), the 12th ... February 8-9 at the Waldorf = ...
Breaking Biology Technology:New technology detects chemical weapons in seconds 2New antioxidant compounds have been identified in foods such as olive oil, honey and nuts 2Renova Life Inc. Joins Mtech Incubator 2Renova Life Inc. Joins Mtech Incubator 3NOVAVAX to Present at the 12th Annual BIO CEO & Investor Conference 2
... four, six and eight port right-angle BNC connectors to its product ... as a replacement for applications where a number of single or ... ... Sunnyvale, CA (PRWEB) April 29, 2009 -- Regal Electronics has ...
... - Strong Focus on the Markets of Pharma & Life Science ... of EUR0.40 per Share , The Annual ... per share following the record year in 2008. , ... results.,Gerresheimer achieved sales of EUR1.06 billion (prior year EUR957.7m) and,operating results ...
... Symbol: MSEDMONTON, April 29 /PRNewswire-FirstCall/ - BioMS Medical Corp (TSX: ... (MS), today announced that Mr. Kevin Giese, President and CEO, ... the development of a world class technology sector" as part ... WHEN: Monday May 4th ...
Other Biology Technology:Regal Introduces Four, Six and Eight Port Filtered and Un-Filtered Right Angle BNC Connectors 22008 a Record Year for Gerresheimer 2BioMS Medical to present at Alberta Economic Forum in Geneva 2
(Date:2/7/2010)... (NCI) have found that the prevalence of tamoxifen use ... a personal history of breast cancer is very low. ... breast cancer in women who are at increased risk ... published in the February issue of Cancer Epidemiology, ... Association for Cancer Research. , The low prevalence ...
(Date:2/7/2010)... more soft drinks per week increased the risk of ... who did not consume soft drinks, according to a ... a journal of the American Association for Cancer Research. ... of the most deadly, and only 5 percent of ... , Mark Pereira, Ph.D., senior author on the study ...
(Date:2/7/2010)... drug that inhibits serotonin synthesis in the gut, administered ... rats reports an international team led by researchers from ... of Nature Medicine . Serotonin in the gut ... formation. The finding could lead to new therapies that ... only prevent the breakdown of old bone. , "New ...
Breaking Biology News(10 mins):Few women take tamoxifen to prevent breast cancer 2Soft drink consumption may increase risk of pancreatic cancer 2Inhibiting serotonin in gut could cure osteoporosis 2Inhibiting serotonin in gut could cure osteoporosis 3Lifestyle interventions in the prevention and treatment of cancer 58289 1MSU scientist helps map potato genome hope to improve crop yield 10097 1MSU scientist helps map potato genome hope to improve crop yield 10097 2Southern California Venture Network to Recognize Local Companies At 2009 Emerging Growth Awards 14266 1Southern California Venture Network to Recognize Local Companies At 2009 Emerging Growth Awards 14266 2
... are abdominal obesity and high levels of a type of ... a person,s risk for stroke. The potential complications are serious: ... kidney disease and stroke. , Preserving the ... a type of poly-unsaturated fat thought to play an important ...
... Researchers at the National Institute of Environmental Health Sciences ... Duke University have discovered a cause of airway irritation ... air pollutant. Using an animal model, the researchers were ... airways from narrowing. These findings help identify potential new ...
... A new study funded by NOAA and the National ... of Juan de Fuca, which separates Washington state from ... toxic harmful algal blooms affecting the Washington and British ... and move is critical for accurate forecasts that could ...
Other Biology News:Fighting obesity and illness with a novel approach to nutrition 2Fighting obesity and illness with a novel approach to nutrition 3Research finds new cause of ozone wheezing and potential treatments 2Scientists discover 'hot spot' for toxic HABS off Washington coastline 2
...
Contains L-glutamine...
... MW 140kDa GenBank Accession ... spanning amino acids 926-941 (DKKVKPPFIPTIRGRE) of human ... Quality Assurance Routinely evaluated ... cells. Stability 1 year ...
...
Biology Products: